Immersion Games S.A. (WSE:IMG)

Intra-Cellular Therapies Balance Sheet

Financials in millions PLN. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023
Cash & Equivalents	0.23	0.2	0.4
Cash & Short-Term Investments	0.23	0.2	0.4
Cash Growth	32.17%	-49.36%	-
Accounts Receivable	-	0.01	0.1
Other Receivables	0.29	0.29	0.06
Receivables	0.29	0.3	0.17
Inventory	0.59	0.6	2.58
Total Current Assets	1.1	1.1	3.14
Property, Plant & Equipment	-	-	0
Long-Term Deferred Tax Assets	0	0	0
Total Assets	1.1	1.1	3.14
Accounts Payable	0.15	0.29	0.31
Accrued Expenses	0.46	0.07	0.07
Current Income Taxes Payable	0	0	0
Current Unearned Revenue	-	0.4	0.95
Other Current Liabilities	0	0.14	0.18
Total Current Liabilities	0.61	0.91	1.51
Long-Term Deferred Tax Liabilities	0	0	0
Total Liabilities	0.61	0.91	1.51
Common Stock	3.21	3.21	3.21
Additional Paid-In Capital	-	-	1.01
Retained Earnings	-2.72	-3.01	-2.58
Shareholders' Equity	0.49	0.19	1.63
Total Liabilities & Equity	1.1	1.1	3.14
Net Cash (Debt)	0.23	0.2	0.4
Net Cash Growth	32.17%	-49.36%	-
Net Cash Per Share	0.07	0.06	-
Filing Date Shares Outstanding	3.21	3.21	-
Total Common Shares Outstanding	3.21	3.21	-
Working Capital	0.49	0.19	1.63
Book Value Per Share	0.15	0.06	-
Tangible Book Value	0.49	0.19	1.63
Tangible Book Value Per Share	0.15	0.06	-
Machinery	-	-	0.02

Source: S&P Global Market Intelligence. Standard template. Financial Sources.